Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.44 which represents a slight increase of $0.43 or 1.65% from the prior close of $26.01. The stock opened at $26.01 and touched a low ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health agencies, among other moves that have sent waves through the biopharma industry.

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

M&A activity in the F&B industry is set to rise in 2025, driven by favorable economic conditions and strategic acquisitions ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

The Hancock County Commission will be receiving additional funds as part of an antitrust lawsuit filed by the State of West ...

Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the ...

Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

The Hancock County Commission has been informed by the West Virginia Attorney General's Office that it will receive $30,000 in the first quarter of 2025.The pay ...

U.S. drugmaker Pfizer PFE.N is going “all in” to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan ...

Corporation, a biopharmaceutical company specializing in proprietary therapeutics with a market capitalization of $14 billion ...